Market Reports Center One Stop Market Research Shop Renal Denervation Market Share, Size, Price, Growth, Trends and Forecasts 2016 - 2020 Renal Denervation is an innovative technology offering an alternative solution for patients who are unable to lower their blood pressure through pharmaceutical means. It is estimated that over 22% of adults have high blood pressure, making hypertension one of the most prevalent global diseases. While this technology has not hit the market as quickly as originally expected, due in part to unmet endpoints in a clinical trial in 2013, Global Data expects the renal denervation market to expand significantly in the coming years. This report will identify the unmet needs with current devices, discuss recently completed and ongoing clinical trial trends and how their results are expected to impact market landscape, and analyze the renal denervation markets outlook by geography and technology. The report provides up-to-date information and in-depth analysis on the key players that shape the global renal denervation market. The report also includes analysis of company profiles, industry trends, and corporate strategy. This report is built using data and information sourced from secondary sources and primary research interviews with Key Opinion Leaders. Download Brochure now @ https://marketreportscenter.com/reports/314779/renal-denervationcurrent-and-future-players *This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase. Scope - Investigation of current and future market competition in the renal denervation market. - Competitive Assessment including product profiles. - Pipeline Assessment of emerging technology. - Coverage of key market players, which includes company profiles, business descriptions, financial overviews, portfolio assessments, and SWOT analyses. - Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis. Reasons to buy - Gain a high level view of the trends shaping and driving the renal denervation market. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. Request for discount @ https://marketreportscenter.com/request-discount/314779 Table Of Content 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Catalyst 2.2 Related Reports 3 Market Access 3.1 The Symplicity HTN-3 Trial 3.2 Reimbursement 3.2.1 Europe 3.2.2 Russia 3.2.3 Australia 3.3 M&A/Key Partnerships 3.3.1 The Cardinal Health Acquisition of Cordis 3.3.2 The Boston Scientific Acquisition of Vessix Vascular 3.3.3 The Medtronic Acquisition of Ardian 4 Competitive Assessment 4.1 Company Share Analysis 4.2 Major Players 4.2.1 Ablative Solutions 4.2.2 Boston Scientific 4.2.3 CardioSonic 4.2.4 Cordis Corporation 4.2.5 Kona Medical 4.2.6 Medtronic 4.2.7 ReCor Medical 4.2.8 Renal Dynamics 4.2.9 St. Jude Medical 4.2.10 Terumo 4.3 Emerging Players 5 Appendix 5.1 Bibliography 5.2 Abbreviations 5.3 Methodology 5.3.1 Overview 5.3.2 Coverage 5.4 Forecasting Methodology 5.4.1 Overview 5.4.2 Patient Population 5.4.3 Procedure Volume by Type of Disease 5.4.4 Procedure Volume by Type of Device 5.4.5 Average Selling Price 5.5 Primary Research Efforts 5.6 About the Authors 5.6.1 Brigitte Babin, MSc, Analyst, Medical Devices 5.6.2 Linda Tian, MSc, Managing Analyst, Medical Devices 5.6.3 Tyler Fletcher, BSc, Global Head of Medical Devices 5.7 About GlobalData 5.8 Contact Us 5.9 Disclaimer To Get Request Sample for this Reports: https://marketreportscenter.com/request-sample/314779 For more information content with us; Sam Collins Market Reports Center 1-646-883-3044 (US) [email protected] https://marketreportscenter.com Reports Cent

Renal Denervation is an innovative technology offering an alternative solution for patients who are unable to lower their blood pressure through pharmaceutical means. It is estimated that over 22% of adults have high blood pressure, making hypertension one of the most prevalent global diseases.